James Poole Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by James Poole Limited

Patent Number:
Title:
A Method For Producing And Purifying Rna, Comprising At Least One Step Of Tangential Flow Filtration
Opposition Date:
May 30, 2024
Patent Number:
Title:
Risk-Stratification Of B-Precursor Acute Lymphoblastic Leukemia Patients
Applicant:
Opposition Date:
May 21, 2024
Patent Number:
Title:
Detection Of Cancer Biomarkers Using Nanoparticles
Opposition Date:
May 14, 2024
Patent Number:
Title:
Spatially Distinguished, Multiplex Nucleic Acid Analysis Of Biological Specimens
Applicant:
Opposition Date:
Mar 28, 2024
Patent Number:
Title:
Methods For Modulating Chemotherapeutic Cytotoxicity
Opposition Date:
Mar 27, 2024
Patent Number:
Title:
Nucleobase Editors And Uses Thereof
Opposition Date:
Mar 27, 2024
Patent Number:
Title:
Devices For Blood Sampling
Opposition Date:
Mar 7, 2024
Patent Number:
Title:
Biological Fluid Micro-Sample Management Device
Opposition Date:
Mar 7, 2024
Patent Number:
Title:
Compositions And Methods For T Cell Delivery Of Therapeutic Molecules
Opposition Date:
Feb 5, 2024
Patent Number:
Title:
Identification And Use Of Circulating Nucleic Acid Tumor Markers
Opposition Date:
Jan 26, 2024

Want to track James Poole Limited?

Feel free to send us a message here and we will get back to you